top of page


Our Tinnitus Treatment Solution Through Gene Therapy

GW-TT5 Pipeline

GW-TT5 is a gene therapy designed to treat severe debilitating tinnitus.

There are currently no FDA-approved drugs for the treatment of this indication.

GW-TT5 is currently in pre-clinical development.

US GW-TT5 Target Population

GW-TT5 Target Population

Our Plan For GW-TT5

GW-TT5 Plan
bottom of page